Patients with severe eczema who were treated with the drug dupilumab experienced a reduction in symptoms and improved quality of life, according to a meta-analysis of several clinical trials published in JAMA Dermatology.
Mar 2, 2023
0
94
A weekly dose of dupilumab, a monoclonal antibody, led to a reduction of symptoms and tissue improvement in young adults and adolescents with eosinophilic esophagitis (EoE), according to a new study published in the New England ...
Dec 22, 2022
0
25
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab—a novel, patient-tailored monoclonal antibody therapy—showed promising results both while taking the drug and up ...
Dec 9, 2022
1
70
Thirdhand smoke, or THS, comprises the residual pollutants from tobacco smoke that remain on surfaces and in dust after tobacco has been smoked. It can remain on indoor surfaces indefinitely, causing potentially harmful exposure ...
Oct 11, 2022
0
99
A biologic therapy for very young children with a moderate to severe form of a common skin condition has been shown to be safe and effective in an international trial which involved University of Manchester clinical scientists ...
Sep 15, 2022
0
1242
Atopic dermatitis, a common skin condition affecting both children and adults, is often thought of as an inflammatory disease that arises from a breakdown in the barrier function of the skin. Now a new study pinpoints a cascade ...
Feb 15, 2022
0
70
About 7.5 million Americans suffer from psoriasis, an autoimmune disease that shows up as patches of red, inflamed skin and painful, scaly rashes. Although there are effective treatments for psoriasis, not everyone responds ...
Nov 19, 2021
0
61
A study led by UT Southwestern dermatologists suggests that a common inflammatory skin condition may stem from poorly regulated sex hormones. The finding, published this week in PNAS, could offer an unexpected new target ...
Sep 20, 2021
0
66
The common skin disease atopic eczema (AE) impacts heavily on the life quality and general health of sufferers. Researchers at Karolinska Institutet in Sweden have now evaluated its treatment with internet-delivered cognitive ...
May 19, 2021
0
36
Itch torments its sufferers and can be as debilitating as chronic pain.
Apr 30, 2021
0
57
